Phase 2 Study to Evaluate the Efficacy and Safety of TRL1068 for the Treatment of Chronic Prosthetic Joint Infection of the Knee or Hip Without Exchange Arthroplasty
Latest Information Update: 24 Nov 2024
Price :
$35 *
At a glance
- Drugs TRL 1068 (Primary)
- Indications Bone and joint infections
- Focus Therapeutic Use
- Sponsors Trellis Bioscience
- 08 Oct 2024 New trial record